Lupin receives USFDA approval for Pitolisant Tablets
The approval covers Pitolisant Tablets 4.45 mg and 17.8 mg, bioequivalent to Wakix for the indications in the approved labelling
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin Pharmaceuticals
Lupin recalls 4,113 cartons of oral contraceptive medicine in US market
The affected lot has been produced at the company’s Pithampur-based manufacturing facility in Madhya Pradesh and distributed in…
Lupin gets USFDA approval of sNDA for SOLOSEC (secnidazole) to treat trichomoniasis
SOLOSEC demonstrated a 92.2 per cent clinically and statistically significant cure rate for patients with trichomoniasis based on…
Lupin presents Phase 3 data for Solosec in female patients with trichomoniasis
The company plans to submit a supplemental New Drug Application for Solosec to the FDA for the treatment of trichomoniasis later…
Lupin receives US FDA approval for Fenofibrate tabs
Lupin Pharmaceuticals would commence promoting the product shortly in the US
Lupin has received final approval for its…
Lupin launches generic Diovan tabs
Is indicated for the treatment of hypertension and heart failure